A detailed history of Pale Fire Capital Se transactions in Uni Qure N.V. stock. As of the latest transaction made, Pale Fire Capital Se holds 580,708 shares of QURE stock, worth $7.01 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares
580,708
Previous 336,468 72.59%
Holding current value
$7.01 Million
Previous $1.66 Billion 518.24%
% of portfolio
2.33%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$4.54 - $17.73 $1.11 Million - $4.33 Million
244,240 Added 72.59%
580,708 $10.3 Billion
Q3 2024

Nov 12, 2024

BUY
$3.78 - $10.12 $1.02 Million - $2.74 Million
270,868 Added 412.91%
336,468 $1.66 Billion
Q4 2023

Feb 13, 2024

BUY
$5.63 - $8.27 $30,965 - $45,485
5,500 Added 9.15%
65,600 $444 Million
Q2 2023

Aug 11, 2023

BUY
$11.12 - $22.2 $668,312 - $1.33 Million
60,100 New
60,100 $689 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $564M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.